Clinical Review - Renal colic
Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more
The vaccine known as ACAM-FLU-A, made by the biotechnology company Acambis, targets all strains of influenza A, the type responsible for a pandemic.
Preliminary results from phase one clinical trials involving 79 volunteers have shown that the vaccine is well tolerated and immunogenic.
In a parallel study, the researchers also tested whether the vaccine could offer protection against avian flu.
Using ferrets, which are commonly used in flu research because they are susceptible to human and bird flu, they found that 70 per cent of those that were vaccinated were protected against the H5N1 virus.
sanjay.tanday@haymarket.com
Comment below and tell us what you think
See all commented articles in our Forums and Blogs section
Quick search - use * for an abbreviated search, eg nico*
Quick search - use * for an abbreviated search, eg nico*
Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more
By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more
Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more
Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more
Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more
Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more
Comments
Only registered users may comment. Log in now or register for a free account.